Beta-Blocker Use and 30-Day All-Cause Readmission in Medicare Beneficiaries with Systolic Heart Failure

BACKGROUND: Beta-blockers improve outcomes in patients with systolic heart failure. However, it is unknown whether their initial negative inotropic effect may increase 30-day all-cause readmission, a target outcome for Medicare cost reduction and financial penalty for hospitals under the Affordable...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Med
Main Authors: Bhatia, Vikas, Bajaj, Navkaranbir S., Sanam, Kumar, Hashim, Taimoor, Morgan, Charity J., Prabhu, Sumanth D., Fonarow, Gregg C., Deedwania, Prakash, Butler, Javed, Carson, Peter, Love, Thomas E., Kheirbek, Raya, Aronow, Wilbert S., Anker, Stefan D., Waagstein, Finn, Fletcher, Ross, Allman, Richard M., Ahmed, Ali
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6756434/
https://ncbi.nlm.nih.gov/pubmed/25554369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjmed.2014.11.036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados